IBO manufactures the Straight (axial) Multiunit Abutment for prosthetically-driven multi-implant rehabilitations on the IBO Conical Reactive line (Nobel Active-compatible protocol). This component mounts on the RP & WP (Regular/Wide Platform) implant connection and provides a standardized multiunit prosthetic platform for screw-retained bars, bridges and overdentures.

This reference, HEC-43802, is the Straight variant in the multiunit line and is selected when the prosthetic plan requires no axis correction (axial loading).

The Straight Multiunit Abutment is selected when implants placed with non-axial angulation require prosthetic-axis correction to achieve a passive, parallel multiunit framework. It is a core component in full-arch rehabilitations such as All-on-4®-style protocols, where posterior implants are tilted to maximize bone engagement and the prosthetic axis must be corrected at the Abutment level.

Final selection of angle, height and platform is determined by the treating prosthodontist based on the implant axes, the prosthetic plan and the impression workflow.

The Straight Multiunit Abutment on the RP & WP platform is positioned as informational compatibility with the Nobel Biocare® NOBEL Active® Ø4.3 / 5.0 protocol. IBO supplies independent compatible prosthetic components; final clinical use must be verified against the implant manufacturer's documentation.

Brand names are trademarks of their respective owners. Ibodontit S.L. is an independent manufacturer with no affiliation, sponsorship or endorsement from the listed brands.

IBO Multiunit components are machined from medical-grade Ti-6Al-4V ELI Titanium, Grade 5, in compliance with ASTM F136 and ISO 5832-3. This alloy is selected for its biocompatibility, mechanical strength and chemical stability in the oral environment.

The component features a polished/machined surface at the gingival emergence for soft-tissue compatibility, and tightly toleranced connection geometry at the implant interface to ensure prosthetic passivity and seal integrity.

All materials and processes are subject to full traceability from raw material to final validation.

IBO Multiunit components are supplied in the manufacturer's validated condition for clinical use. Follow the package insert and IBO Instructions for Use for handling, storage and torque protocol. Do not modify the component geometry, surface or connection seat in any way; doing so compromises the prosthetic interface and the regulatory clearance.

Single-use device. Single patient, single procedure. Discard unused components per local biohazard regulations.

IBO operates under ISO 13485:2016 quality management for the manufacturing of medical devices, holds the AEMPS Spanish Agency of Medicines and Medical Devices licence, and every IBO component carries the CE marking MDR, assessed by a Notified Body.

Five quality foundations apply to this component: